Objective. Uveitis is a visually debilitating disorder that affects up to 30% of children with the most common forms of juvenile idiopathic arthritis (JIA). The disease mechanisms predisposing only a subgroup of children to uveitis are unknown. This study was undertaken to identify genetic susceptibility loci for uveitis in JIA, using a genome-wide association study in 522 children with JIA.
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Objective. Uveitis is a visually debilitating disorder that affects up to 30% of children with the most common forms of juvenile idiopathic arthritis (JIA). The disease mechanisms predisposing only a subgroup of children to uveitis are unknown. This study was undertaken to identify genetic susceptibility loci for uveitis in JIA, using a genome-wide association study in 522 children with JIA.
Methods. Two cohorts of JIA patients with ophthalmologic follow-up data were genotyped. Data were then imputed using a genome-wide imputation reference panel, and an HLA-specific reference panel was used for imputing amino acids and HLA types in the major histocompatibility complex (MHC). After imputation, genomewide and MHC-specific analyses were performed, and a reverse immunology approach was utilized to model antigen presentation at 13 common HLA-DRb1 alleles.
Results. Presence of the amino acid serine at position 11 (serine 11) in HLA-DRb1 was associated with an increased risk of uveitis in JIA patients (odds ratio [OR] 2.60, P = 5.43 3 10
À10
) and was specific to girls (P females = 7.61 3 10 À10 versus P males = 0.18). Serine 11 resides in the YST motif in the peptide-binding groove of HLADRb1; all 3 amino acids in this motif are in perfect linkage disequilibrium and show identical association with disease. Quantitative prediction of binding affinity revealed that HLA-DRb1 alleles with the YST motif could be distinguished on the basis of discernable peptide-binding preferences.
Conclusion. These findings highlight a genetically distinct, sexually dimorphic feature of JIA with uveitis as compared to JIA without uveitis. The association could be indicative of the potential involvement of antigen presentation by HLA-DRb1 in the development of uveitis in JIA. The results of this study may advance our progress toward improved treatments for, and possible prevention of, the sight-threatening complications of uveitis in children with JIA.
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in childhood, affecting 16-150 per 100,000 individuals (1) . As many as 1 in 3 children diagnosed as having one of the most common categories of JIA, either oligoarticular JIA or rheumatoid factor (RF)-negative polyarticular JIA, develop chronic anterior uveitis. Uveitis in JIA specifically is a chronic inflammatory eye disease, and is the most frequent extraarticular manifestation of JIA (2) . Uveitis threatens the sight of those affected, and can result in complications, including band keratopathy, cataracts, glaucoma, macular edema, and, in severe cases, hypotony (2) . Because it typically afflicts children younger than age 7 years, uveitis can dramatically impact the quality of life of children and can continue to impact patients into adulthood (2, 3) .
Early detection and adequate ophthalmologic management of JIA-associated uveitis are critical to prevent sight-threatening complications (4, 5) . Despite its severity, chronic anterior uveitis is typically insidious in onset and often becomes symptomatic only after irreversible damage has occurred. Consequently, rigorous ophthalmologic screening of all JIA patients is required for early detection and prompt treatment of uveitis associated with JIA (6). Despite screening, severe ocular complications may already be present at the time of the uveitis diagnosis.
JIA and uveitis are complex, multifactorial autoimmune disorders with both genetic and environmental risk factors (2, 3, 7) . Genome-wide association studies (GWAS) in JIA (regardless of uveitis status) have revealed a number of loci associated with the disease (8-10), which, collectively, can explain~20% of the phenotypic variation (8) . A number of HLA alleles have also been identified as factors that increase the risk of JIAassociated uveitis compared to an unaffected control group (11) . However, genome-wide genetic markers that distinguish JIA without uveitis from JIA with uveitis remain elusive. Furthermore, whereas girls comprise the majority of JIA patients (female-to-male ratio~2:1) (12), the extent to which the biologic risk of developing uveitis in JIA is sexually dimorphic is unknown (12) .
In the present study, we performed genotyping and imputation of the major histocompatibility complex (MHC) in 192 patients with JIA-associated uveitis and 330 JIA patients without uveitis (hereafter referred to as non-uveitis JIA controls), with the aim of identifying those genetic variants that segregate more commonly in JIA patients with uveitis compared to those without uveitis.
PATIENTS AND METHODS
Data collection. We performed data collection, quality control, and statistical analyses in 2 phases, and then jointly analyzed the data from both phases to improve the power of locus discovery (Table 1 ; see also Supplementary Methods, available on the Arthritis & Rheumatology web site at http://onlinelibrary. wiley.com/doi/10.1002/art.40484/abstract) (13) . Analysis code, supporting data files, and links to summary-level data can be found at https://github.com/saralpulit/UveitisJIA_MHC-fineMapping. Samples for genotyping were collected from 2 cohorts: 1) a Dutch cohort, comprising 137 patients with JIA-associated uveitis and 247 non-uveitis JIA control patients (phase 1), and 2) a cohort of samples collected in Germany, Belgium, and Switzerland, comprising 77 patients with JIA-associated uveitis and 115 non-uveitis JIA controls (phase 2). ‡ Includes rheumatoid factor (RF)-positive polyarthritis (n = 4), psoriatic arthritis (n = 6), enthesitis-related arthritis (n = 15), systemic arthritis (n = 3), other arthritis (n = 10), and unknown (n = 3).
Patients were diagnosed as having JIA according to the criteria of the International League of Associations for Rheumatology or the European League Against Rheumatism (14, 15) . Ophthalmologists screened all patients according to the Academy of Pediatrics guidelines (6) , and patients with no clinical signs of uveitis at the time of screening were followed up for at least 4 years after the onset of JIA. Patients in whom trace cells or more abundant cells were found in the anterior chamber and who were treated with at least topical steroids during the ophthalmologic examinations were diagnosed as having JIA-associated (anterior) uveitis.
DNA Genotype data from 398 unrelated and unaffected Dutch subjects were used as population-level controls. These subjects had previously been genotyped using the same platform as used in the present study (16) .
This study was approved by the local Institutional Review Boards and is in compliance with the principles of the Declaration of Helsinki. Informed consent was obtained from all participating patients if they were age 18 years or older, from both parents and patients if they were age 12-18 years, and from only parents if they were younger than age 12 years.
Prephasing and imputation. We genotyped all samples on the Infinium HumanOmniExpress-24 array (version 1.1). In each phase, we performed sample-and variant-level quality control, prephasing, and imputation. We prephased the phase 1 and phase 2 data separately using the ShapeIt2 program (17) . As the sample size was >100 samples, we ran prephasing without a reference panel, in accordance with the ShapeIt2 recommendations. Following prephasing, we imputed the prephased samples using Impute2 software (18) , and an imputation reference panel was constructed using the 2,504 samples that were whole-genome sequenced in the 1000 Genomes Project (phase 3) (19) .
To impute amino acids and HLA alleles in the MHC, we used the SNP2HLA pipeline (20) . This panel includes single-nucleotide polymorphisms (SNPs) and amino acids in the MHC, as well as HLA class I and class II types. HLA types are imputed to 2-and 4-digit resolution. The SNP2HLA pipeline uses the Beagle program (21) to phase and impute the data. Full details on prephasing and imputation can be found in Supplementary Methods (http://onlinelibrary.wiley.com/doi/ 10.1002/art.40484/abstract).
Genome-wide association testing. Our data enabled 3 comparisons: 1) all JIA cases versus population-level controls, 2) JIA-associated uveitis cases versus population-level controls, and 3) JIA-associated uveitis cases versus non-uveitis JIA controls. As we sought to compare the genetic architecture of JIA and uveitis, and because far larger GWAS of JIA and population-level controls have already been completed (22), we performed the first 2 comparisons for the purposes of quality control and to look up known associations (22, 23) Within each study phase, we performed a GWAS, using Plink software version 1.9 (24) , in an additive logistic regression model, with corrections for sex and the first 2 principal components (PCs; to account for sample ancestry) (see Supplementary Methods and Supplementary Figures 3 and 4 , available on the Arthritis & Rheumatology web site at http://onlinelibrary. wiley.com/doi/10.1002/art.40484/abstract). We meta-analyzed the results using the METAL program (25) for a combined analysis of 192 patients with JIA-associated uveitis and 330 non-uveitis JIA controls (Table 1 ). To ensure that we were analyzing SNPs with high-quality imputation, we only analyzed common SNPs (i.e., those with a minor allele frequency of >1%) with an imputation quality (info) score of >0.7. The single signal identified as achieving genome-wide significance (P < 2 9 10 Association testing and fine-mapping in the MHC. To identify the amino acids or HLA types driving the genome-wide association signal, we imputed the MHC region on chromosome 6 using an MHC-specific imputation panel (20) . We merged the imputation dosages from phase 1 and phase 2 to perform a megaanalysis, running a logistic regression across the merged data, with corrections for the top 5 PCs, sex, and analysis phase (i.e., phase 1 or phase 2). To ensure that this mega-analysis approach was appropriate, we additionally performed an inverse varianceweighted meta-analysis (26, 27) of the 2 phases. We found that the results were highly concordant (r = 0.95 for Pearson's correlation of genome-wide b values; see Supplementary Methods and Supplementary Figure 5 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/art.40484/ abstract). Our mega-analysis approach has the additional advantages of allowing for interaction testing and conditional analysis. To identify independent signals within the MHC, we performed conditional analyses (results shown in Figure 1) .
In silico prediction of peptide binding to HLA-DRb1. We used proteome data from human iris tissue (2,959 nonredundant proteins) as a representative source of proteins present in iris tissue (28) . Patients with JIA-associated uveitis commonly have antinuclear antibodies (ANAs) and antibodies directed to iris tissue, and therefore we focused on nuclear iris proteins to generate a potentially disease-relevant data set. We selected 147 proteins that fulfilled these criteria (see Supplementary Table 2 , available on the Arthritis & Rheumatology web site at http:// onlinelibrary.wiley.com/doi/10.1002/art.40484/abstract), and their full-length amino acid sequences were fed into the neural network of the netMHCIIpan3.1 server.
We next tested the predicted affinities of all 83,686 overlapping 15-mer peptides from the selected 147 proteins in netMHCIIpan3.1 for binding to representative 4-digit alleles of HLA-DRB1. The affinity data were log-transformed to a value between 0 and 1 using the calculation 1 À log(IC 50 nM )/log(50,000) (29) , where IC 50 nM represents the half maximal inhibitory concentration.
To categorize HLA-DRB1 allotypes with similar predicted binding preferences, we performed unsupervised hierarchical clustering and generated heatmaps based on the Euclidean distance measure and the Ward's linkage method, using the MetaboAnalyst server (30) . We computed the ratio of the average binding affinity of HLA-DRb1 molecules that contain serine 11 in the peptide-binding groove to the average binding affinity of HLA-DRb1 proteins that have other amino acids at this position, as a measure of the overall difference in predicted binding affinity for each peptide.
RESULTS
Of the SNPs, amino acids, and classic alleles tested in the MHC for an association with uveitis in JIA (see Supplementary Table 3 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.40484/abstract), we observed the strongest association with the presence of either serine or aspartic acid at position 11 in HLA-DRB1 (odds ratio [OR] 2.59, 95% confidence interval [95% CI] 1.92-3.50; P = 4.80 9 10 À10 ) ( Figure 1A and Table 2 ). To identify which of the possible residues at position 11 explained the signal, we first performed an ; purple diamond). B, Conditioning on the presence of aspartic acid at position 11 (green and white diamonds, gray outline) left the association signal essentially unchanged, while presence of serine (pale purple diamond) remained the strongest association. Conditioning on the presence of serine at position 11 (aquamarine and white diamonds, black outline) dramatically mitigated the association signal, indicating that the presence of serine explains the bulk of the association at DRB1 position 11. Presence of lysine (K) at position 69 in HLA-DPB1 (dark purple diamond) remained modestly associated. C, Conditioning on lysine at position 69 in HLA-DPB1 (rs6457109, dark purple diamond) removed the remainder of the signal (P = 0.0024). LD = linkage disequilibrium.
omnibus test of all but 1 of the 6 alleles present at HLA-DRB1 position 11 as compared to a null model. We found that the goodness-of-fit of the omnibus test far exceeded that of the null model (which included only the variables of sex, PCs, and study phase) (likelihood ratio test P = 1.5 9 10 À9 ). Next, to test whether a single HLA-DRB1 position 11 allele was driving the top association signal (as * These are the top results from the mega-analysis of HLA-DRB1 in samples from patients with juvenile idiopathic arthritis (JIA)-associated uveitis (cases) versus JIA patients without uveitis (controls). All reported results correspond to the presence of the given amino acid residues. Presence of serine (Ser) or aspartic acid (Asp) at position 11 in HLA-DRB1 (imputation info score 1.11) was the top hit after initial association testing. Conditioning on either aspartic acid or serine revealed that the amino acids at positions 10-13, all well-imputed (imputation info score 1.08) and in perfect linkage disequilibrium, explain the bulk of the initial signal. Association statistics for tyrosine (position 10), threonine (Thr) (position 12), and serine or glycine (position 13) are identical to the association statistics reported for serine (position 11) due to linkage disequilibrium. OR = odds ratio; 95% CI = 95% confidence interval.
HLA-DRb1 YST MOTIF IN JIA-ASSOCIATED UVEITIS
opposed to all possible alleles together, as modeled by the omnibus test), we performed conditional testing of the top association signal by first including the imputation dosages for serine, and then separately including aspartic acid at position 11 as an additional covariate in the logistic regression model ( Figure 1B and Table 2 ). After conditioning on serine 11, the association signal dropped substantially (P = 0.069), whereas conditioning on aspartic acid at position 11 left the signal essentially unchanged (OR 2.60, 95% CI 1.92-3.52; P = 5.43 9 10
À10
), indicating that the presence of serine explains the bulk of the signal.
The association with the presence of serine at position 11 in HLA-DRB1 was consistent both in the phase 1 cohort (OR 2.15, 95% CI 1.52-3.05; P = 1.59 9 10
À5
) and in the phase 2 cohort (OR 3.34, 95% CI 1.92-5.83; P = 2.11 9 10 À5 ), indicating that both study phases contributed to the signal identified as showing genome-wide significance in the overall mega-analysis (13) . In separate subset analyses of samples from patients with oligoarticular (extended or persistent) JIA or RF-negative polyarticular JIA, which represent the phenotypes in which typical chronic anterior uveitis most commonly occurs, the association results were not affected (for serine 11, OR 2.42, P = 1.72 9 10 HLA-DRB1 serine 11 is positioned in the middle of what is known as the YST motif (31, 32) . The motif is composed of tyrosine (Y) at position 10, serine (S) at position 11, and threonine (T) at position 12. All 3 amino acids are in perfect linkage disequilibrium (LD) with one another (i.e., r 2 = 1 between all residue pairs). Additionally, the residues in the YST motif are in near-perfect LD (r 2 = 0.9999994) with a fourth residue, the presence of serine or glycine at position 13 (OR 2.47, 95% CI 1.84-3.32; P = 1.44 9 10
À9
). Thus, all 4 amino acid configurations show identical, statistically significant associations with JIA-associated uveitis (Table 2) .
To further decipher the specific residues across positions 10-13 driving the association in uveitis, we performed a series of likelihood ratio tests. Briefly, a likelihood ratio test compares the fit of 2 models to the observed data and indicates if either model best fits that data. First, as expected, we found that a model containing serine 11 (or tyrosine 10 or threonine 12) best fit the data (P = 1.48 9 10 À10 , compared to a model containing only PCs and sex as variables), a finding that is consistent with the results from our initial association testing.
We next combined the serine or glycine residue at position 13 with the YST motif in a single model, and compared that model to 1 containing the PCs, sex, and serine 11. The model including serine/glycine 13 only modestly improved the model fit (likelihood ratio test P = 0.043); neither serine 13 nor glycine 13 alone improved the model (P = 0.70 for both tests).
We then wanted to test whether the uveitis-associated serine 11 signal was independent of associations previously observed in all patients with JIA (including uveitis cases) found at HLA-DRB1 serine 13 and glycine 13 (22) and replicated in our own data (for results, see Supplementary Table 4 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.40484/abstract). We observed a modest LD between serine 11 and serine 13 (r 2 = 0.621) and between serine 11 and glycine 13 (r 2 = 0.104). Conditioning serine 11 on serine 13 in our comparison of patients with JIA-associated uveitis and non-uveitis JIA patients, we found that the serine 11 signal was modestly affected (OR 2.61, 95% CI 1.74-3.93; P = 3.83 9 10 À6 ). Similarly, conditioning on glycine 13 revealed a modest signal change (OR 2.41, 95% CI 1.75-3.32; P = 6.49 9 10 À8 ). These results indicate that the association signal at serine 11 primarily represents an effect that is independent of that of serine 13 and glycine 13 in all patients with JIA.
Sexual dimorphism in JIA-associated uveitis. As uveitis is epidemiologically known to be more prevalent in female patients with oligoarticular JIA (33), we wanted to formally test whether the genetic association signal in uveitis was sexually dimorphic. In analyzing female patients only (136 samples from girls with JIA and uveitis versus 228 samples from girls with JIA without uveitis), we found a genome-wide significant signal at serine 11 in HLA-DRB1 (OR 3.30, 95% CI 2.26-4.83; P = 7.61 9 10
À10
). We found no evidence of association with serine 11 in male patients (56 boys with JIA and uveitis versus 102 boys with JIA without uveitis) (OR 1.41, 95% CI 0.86-2.31; P = 0.177) ( Table 2 Figure 7 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10. 1002/art.40484/abstract), and consequently yields a nearly identical association to that at serine 11 ( Table 2) .
To further explore the potential for a sex-specific effect, we ran the association test at serine 11 across all samples and included an interaction term between sex and the imputed dosage for presence of serine 11. We found a significant effect of the interaction term (OR 2.25, 95% CI 1.22-4.15; P = 0.0096), indicating that the HLA-DRB1 serine 11 signal was indeed sex specific. When we reduced our analysis to the subsets of patients with oligoarticular (extended or persistent) JIA and those with RF-negative polyarticular JIA, the interaction results remained unchanged (P = 0.0121) (see Supplementary Results, available on the Arthritis & Rheumatology web site at http:// onlinelibrary.wiley.com/doi/10.1002/art.40484/abstract).
In silico peptide binding to HLA-DRb1. Polymorphisms in the HLA-DRB1 b-chain specify the peptidebinding preference of HLA-DR. The YST motif containing serine 11 is located in the bottom of the antigenbinding groove of the HLA-DR protein (Figure 2) , suggesting that different peptide-binding preferences of HLA-DRB1 may confer a risk of uveitis. To explore whether the presence of serine 11 affects peptide-MHC class II interactions, we compared the predicted binding affinity for 13 common HLA-DRB1 allotypes (representing 79% of the DRB1 alleles in JIA cases) using a panel of >80,000 peptides based on proteome data from human iris tissue (see Supplementary Results and Supplementary Table 2 , available on the Arthritis & Rheumatology web site at http://on linelibrary.wiley.com/doi/10.1002/art.40484/abstract) implemented in the NetMHCIIpan server (29) . The neural network-based NetMHCIIpan algorithm is capable of reliably detecting differences between peptide-binding repertoires of highly similar MHC class II molecules (29) .
To compare predicted binding preferences, we performed unsupervised hierarchical clustering on the binding profiles of all DRB1 alleles; clustering discerned 2 major clusters of classic alleles strikingly similar to the distribution of serine at position 11 (results in Supplementary Figure 8 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/art. 40484/abstract). We observed that the average binding affinity of the peptide panel was higher for the HLA-DRB1 alleles that encode serine at position 11 than for the alleles that have other amino acids at this position (P = 3.44 9 10
À136
, by Wilcoxon signed rank test) (results in Supplementary To compare these 2 clusters, we computed the ratio of the average binding affinity of the 6 HLA-DRB1 allotypes that contain serine 11 and the average binding affinity of the 7 allotypes that have other amino acids at this position (see Supplementary Table 5 , http://onlinelibrary. wiley.com/doi/10.1002/art.40484/abstract). Since MHC class II molecules at the cell surface present repertoires that are skewed in favor of high-affinity binders (29), we selected for those peptides that had an affinity (IC 50 nM ) of <500 nM (an affinity of <500 nM is routinely used as a threshold for potential immunogenicity) or <50 nM (strong binding peptides) for HLA-DRB1 allotypes with serine 11 (see Supplementary Methods, http://onlinelibrary.wiley.com/ doi/10.1002/art.40484/abstract). The data indicated that peptides with an intermediate or high affinity for allotypes containing serine 11 had less affinity to allotypes that contained other amino acids at position 11 (for results, see Supplementary Table 5 , http://onlinelibrary.wiley.com/doi/ 10.1002/art.40484/abstract).
DISCUSSION
Through interrogation of imputed HLA types and amino acids, we have identified the amino acid serine at position 11 in the HLA-DRB1 gene as being strongly associated with an increased risk of uveitis in female JIA patients. The perfect LD observed across the YST motif (positions 10-12) makes it impossible to disentangle the 3 amino acids in a statistical framework; a subset of the amino acids, all 3 (i.e., the complete YST motif), or a more complex interaction of these variants with others in the region may all be key to disease onset. Interrogation of larger sample collections and extensive functional work in this region will be necessary to fully understand the mechanism(s) driving the association. Nevertheless, our findings indicate that, although JIA with uveitis and JIA without uveitis share clinical features and HLA-specific genetic risk factors (23) , there appear to be genetic signals that are specific to JIA with uveitis.
Further analyses revealed that the serine 11 signal is sexually dimorphic and unique to female patients with JIA. The reduced number of male patients with JIAassociated uveitis (Table 1 ) and resulting reduced power in the male-only analysis may explain the absence of association signal. However, we had 98.5% power to detect an association (P < 0.05) at serine 11 in the male-only analysis, assuming that the OR in male patients was the same as in female patients (OR 3.30) . Assuming a more modest effect in male patients (OR 2.00), we still had 75.2% power to detect a signal at P < 0.05. To detect more subtle effects in male patients or other lower-penetrance, sexually dimorphic effects in either sex, larger case collections will be necessary.
Although JIA-associated uveitis is known to occur more frequently in girls (33) , more detailed sex-specific epidemiologic data in JIA-associated uveitis are sparse. The genotype-by-sex interaction informs an exciting field of future research aimed at elucidating potential sexspecific uveitis risk mechanisms (e.g., hormone regulation) underlying the HLA-DRB1 signal. The sexually dimorphic serine 11 association (or the complete YST motif) may also help explain the previously reported evidence of sexually dimorphic severity or course of the disease in children with JIA-associated uveitis (34) . Moreover, the findings indicate that sex stratification may be beneficial for future clinical trials, as some therapeutic agents may be more efficacious in female patients only or in male patients only (35) .
Although all 3 YST-motif residues reside at the bottom of the HLA-DRB1 peptide-binding groove, only serine 11 is positioned toward, and thus most likely interacting with, binding peptide epitopes (Figure 2 ). Previous work has identified serine 11 as the strongest risk factor in seronegative rheumatoid arthritis (RA) (36) . Some JIA patients with uveitis might be categorized as having seronegative RA by the time that they reach adulthood, and seronegative RA is considered to genetically mirror the uveitis-prone JIA categories (22) . In contrast, serine 11 is highly protective against seropositive RA, a biologically distinct form of RA in which uveitis is not common (<1% of cases) (37) .
HLA-DRb1 is essential to immunity and orchestrates the downstream immune response by presenting a dynamic cargo of thousands of different peptides for scrutiny by T helper cells (38) ; both JIA and uveitis are thought to be mediated by T helper cell subsets (2) . A potential explanation for the strong association of an amino acid motif (tagged by serine 11) in HLA-DRB1 is that predetermined peptide preferences may affect T helper cell regulation. Although the large panel of putative antigens that we tested (see Supplementary Table 2 , http://onlinelibrary.wiley.com/ doi/10.1002/art.40484/abstract) was by no means exhaustive, the experiment demonstrated that the presence of serine 11 in HLA-DRB1 is accompanied by changes in binding affinity in the resulting protein (see Supplementary Table 5 and Supplementary Figure 8 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/art. 40484/abstract), suggesting that antigen presentation by the HLA-DRb1 protein may (partially) underpin the susceptibility to uveitis. HLA-DRB1 risk alleles that encode serine 11 (Supplementary Table 3 ). Functional studies using HLA-proteomic approaches will be necessary to experimentally validate and systematically dissect the complex downstream effects of serine 11 on tissue-specific antigen presentation by HLA-DRb1 in uveitis.
The relatively high frequency of serine 11 in the JIA patients who did not develop uveitis (Table 2) indicates the likely involvement of additional (epi)genetic and environmental factors in uveitis. Only a handful of candidate gene studies (2, 39) , HLA-specific analyses (23) , and a recent GWAS (40) have investigated uveitis as a phenotype separate from JIA overall, with the latter study identifying HLA-DRB1*1501 as a uveitis risk factor. Genes outside the MHC have also been implicated in JIA-associated uveitis, including a polymorphism in VTCN1 (41) and variants near the immune genes TRAF1 and C5 (42) . Other studies have implicated a role for infiltrated plasma cells (43) , T helper cells (2) , and changes in the ocular fluid microenvironment (44) (45) (46) . Although our study was well powered to detect common (frequency >10%) and highly penetrant (OR >3 [ Supplementary Figure 9] ) genetic variations that were associated with increased uveitis risk, the study was underpowered to identify common (frequency 1-10%), modestly penetrant variants (ORs 1.05-1.5), which are the hallmark genetic feature of complex phenotypes (47, 48) . Future studies will need to interrogate much larger samples from an array of global populations (49) in order to identify additional genetic signals that influence disease risk.
A number of risk factors, including young age and presence of ANAs (assumed to reflect aberrant immune activation [50] ), are used to regularly screen (~4 times/ year) JIA patients for early detection of uveitis. However, a considerable number of uveitis cases are diagnosed after sight-threatening complications have already occurred (6) . A biomarker test, such as a test for the presence of serine 11, would significantly simplify the diagnosis and prevent unnecessary ophthalmologic screening in JIA patients who have a low susceptibility to uveitis (4) . Deeper examination of our phenotypic data showed that 99% of female JIA patients with uveitis carried at least one copy of the variant coding for serine 11. The only female JIA patient with uveitis who lacked serine 11 in HLA-DRB1 appeared to have ANA-negative oligoarthritis with mild vitritis and peripheral multifocal choroiditis in the absence of anterior segment inflammation. This ocular finding is atypical for JIA, and thus, according to our inclusion criteria, this sample was likely improperly included at cohort collection. Prospective studies in larger populations, including detailed clinical evaluation of development of uveitis and secondary uveitis phenotypes, will be necessary to dissect the potential of serine 11 or other genotypes to serve as biomarkers for disease risk. Regardless, the current study justifies further genetic analysis.
The results of our study represent a key step in understanding the pathogenesis of uveitis in JIA, helping to discern biologically shared and distinct features of JIAassociated uveitis and JIA without uveitis. Future work will allow us to further disentangle the 2 phenotypes, evaluate shared and distinct disease etiology, identify disease pathways, and evaluate the efficacy of serine 11 or other genetic markers as potentially efficient clinical decision-making tools. By pinpointing and understanding the molecular mechanisms of uveitis, we can identify biomarkers that stratify patients for disease risk, catalyze future lines of research in precision medicine, and make advancements toward improving the treatment and prevention of sightthreatening complications of uveitis in children with JIA.
